SCHEMBL7632697

SCHEMBL7632697

Cc1ccc(C(=O)c2cc(Br)c(C)cc2O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.50
▸ ALDH1A1 P00352 3/20 0.48
▸ LMNA P02545 2/20 0.48
▸ NPC1 O15118 3/20 0.46
▸ HTT P42858 3/20 0.46
▸ CNR1 P21554 1/20 0.46
▸ CNR2 P34972 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ AKR1C3 P42330 1/20 0.45
▸ RAB9A P51151 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ GAA P10253 1/20 0.44
▸ COMT P21964 2/20 0.43
▸ ABCC3 O15438 1/20 0.43
▸ ABCC4 O15439 1/20 0.43
▸ NR1I2 O75469 1/20 0.43
▸ ABCB11 O95342 1/20 0.43
▸ TTR P02766 1/20 0.43
▸ NR3C1 P04150 1/20 0.43
▸ PGR P06401 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3140410 0.82 ALDH1A1 (0.60) MAPTALDH1A1LMNANPC1HTT
SCHEMBL4085402 0.81 HSD17B1 (0.43) MAPTALDH1A1LMNANPC1HTT
SCHEMBL28126760 0.80 HPGD (0.54) MAPTALDH1A1LMNAHTTCNR1
SCHEMBL7627046 0.80 MAPT (0.54) MAPTALDH1A1LMNANPC1HTT
SCHEMBL7633062 0.78 MAPT (0.69) MAPTALDH1A1LMNANPC1HTT
SCHEMBL30070764 0.77 CSNK2A1 (0.62) MAPTALDH1A1LMNANPC1HTT
SCHEMBL11350747 0.77 NPC1 (0.64) MAPTALDH1A1LMNANPC1HTT
SCHEMBL29229973 0.76 AKR1C3 (0.61) MAPTALDH1A1LMNANPC1HTT
SCHEMBL24419776 0.75 ALDH1A1 (0.61) MAPTALDH1A1LMNANPC1HTT
SCHEMBL20157430 0.75 MAPT (0.60) MAPTALDH1A1LMNANPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0975573-B1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY ALLERGAN SALES INC (US) 2002-09-18 — — EP disclosed
US-6235923-B1 RETINOIDS AND CELL DIFFERENTIATION ALLERGAN SALES, INC. 2001-05-22 — — US disclosed
US-6225494-B1 TREATING SKIN DISORDERS, REDUCED SIDE EFFECTS ALLERGAN SALES, INC. 2001-05-01 — — US disclosed
US-6037488-A COMPOUNDS SUCH AS 4-((4'-ISOPROPOXY-3'-(1-M-TOLYL)VINYL)PHENYLETHYNYL)BENZOIC ACID ALLERGAN SALES, INC. (US) 2000-03-14 — — US disclosed
EP-0975573-A1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY Allergan Sales, Inc. (US) 2000-02-02 — — EP disclosed
WO-1998047854-A1 TRISUBSTITUTED PHENYL DERIVATIVES HAVING RETINOID AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY ALLERGAN SALES, INC. (US) 1998-10-29 — — WO disclosed
Send feedback